View Author
patient lesion score stent group syntax euroscore revascularization outcome study trial vessel intervention disease artery sxscore syntax score ulm disease table angiographic surgery death follow-up fication percutaneou result assessment signi model artery disease event cardiol risk strati fication treatment randomized ll >13.4 mm variable rvd >2.65 mm stent thrombosis ll <13.4 mm risk models tertile risk assessment paclitaxel-eluting analysis spirit mortality group c thrombosis infarction length macce strati paclitaxel-eluting stents syntax score tertile 2- year mace system ability revascularization strategy registry american college american ulm lesions lesion length additive euroscore classi diameter everolimus-eluting paclitaxel-eluting stents jacc heart patients randomized ͻ0.01 group b predictor signi ficantly lesion complexity restenosi creatinine value cardiology
2 Most Recent Publications
|
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents: Pooled analysis from the SPIRIT (Clinical evaluation of the XIENCE v everolimus eluting coronary stent system) and COMPARE (second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) randomized trials
(Article)
Claessen, B.E. Smits, P.C. Sood, P. Simonton, C. Stone, G.W. Kereiakes, D.J. Parise, H. Fahy, M. Kedhi, E. Serruys, P.W.J.C. Lansky, A.J. Cristea, E. Sudhir, K. |
2011-11-01
|
|
Clinical and angiographic risk assessment in patients with left main stem lesions
(Article)
Garg, S.A. Stone, G.W. Kappetein, A.P. Sabik, J.F. Simonton, C. Serruys, P.W.J.C. |
2010-09-01
|